Ana-Maria Oros-Peusquens1, Ricardo Loucao1, Elene Iordanishvili1, Melissa Schall1, Markus Zimmermann1, Svenja Caspers2, and N. Jon Shah1
1Institute of Neuroscience and Medicine 4, Medical Imaging Physics, Research Centre Juelich, Juelich, Germany, 2Institute of Neuroscience and Medicine 1, Research Centre Juelich, Juelich, Germany
Synopsis
Type II diabetes is one of
the most important metabolic disorders for public health with around 8%
prevalence in European population (11% in the US). We report here for the first
time a generalized increase in brain water content of ~ 2% in type II diabetics
compared to age- and gender-matched controls, supporting the presence of
neuroinflammation in diabetes. Several other quantitative measures are
investigated (T1, T2*, MT parameters, magnetic
susceptibility and diffusion kurtosis) as well as region-based volume, area and
cortical thickness. Regions with significant changes in a large number of quantitative
parameters are identified.
Introduction
Type II diabetes mellitus (T2DM) is one
of the most important metabolic disorders for public health [1], reaching ~8% prevalence in normal european population
(11% in the US). The central nervous system is affected by T2DM; among others, myelopathy
and encephalopathy, [2] cognitive impairment and increased risk of dementia [3]
have been described. Exacerbation of neurodegeneration by hyperglycemia is
reported in T2DM [4]. Total grey, white matter and hippocampal are atrofied in
diabetic patients [5]. Furthermore, diabetes has been associated with low grade
systemic inflammation and neuroinflammatory processes [6], but quantitative
in-vivo measurements of brain inflammation were still lacking.
We report here for the
first time in-vivo non-invasive detection of brain oedema levels in type
II diabetic patients. Other quantitative parameters reflecting myelination,
iron content and presence of cellular compartments
and membranes are also investigated.
Materials and Methods
The preliminary results include 7
subjects with T2DM and 7 age, gender and education-matched controls not
affected by metabolic syndrome (all male, age=69.6±5.5 and 67.3±5.8). The
subjects have been drawn from the population-based cohort study 1000BRAINS, which
aims at assessing the influence of environmental and genetic factors on the
variability of structure and function of the aging brain[7]. Only subjects
without notable white matter hyperintensities were selected.
The quantitative parameters H2O,
T1, T2* and MT measures (magnetisation
transfer ratio MTR, exchange rate kex , bound proton fraction fbound)
were derived using a 3D 2-point method similar to that described in [8], to
which a magnetisation transfer was added. The protocol consists of five sequences:
an M0-weighted (α=7◦) and a T1-weighted multi-echo gradient echo
(meGRE) (α=40◦)
both with and without MT (off-resonance frequency -1.5kHz), respectively, and
an actual flip angle sequence [9] (AFI) (α=40◦) to map the transmit field, B1+.
Other imaging parameter for the meGREs (AFI) were set as follows: TR=50ms
(150ms), 18 echoes (12 for MT preparation), 1x1x2mm3 resolution
(2.8x2.8x4.0mm3), matrix size 162x192x96 (54x64x48), bandwidth
650Hz/px (330Hz/px), phase and slice partial Fourier 6/8, parallel imaging
using GRAPPA factor 2 with 24 reference lines. The total acquisition time for
the quantitative protocol was TA=14:20min. Magnitude and phase images were
saved and processed with in-house software (written in python) and STISuite
[10]. In addition, an extensive
diffusion protocol (b-values of 1000 and 2700 s/mm2, 60+120
directions) and a standard T1-weighted anatomical scan (MP-RAGE) were acquired
as described in [7].
VBM analysis using CAT12/SPM12
was performed (2 sample t-test, cluster size >100 voxels, p<0.01
uncorrected) using the anatomical scans. Kurtosis tensor analysis was performed
using MIBCA [11]. The quantitative maps were registered to the MNI template and
averaged for each group (T2DM vs controls) and the two averaged sets of
parametric maps were compared.
Parcellation of the
brain in each individual space using FreeSurfer defined ROIs for region-based
comparison. Changes in structural connectivity of the brain was performed with
MIBCA using tractography based on diffusion kurtosis tensor analysis [9].
Correlations between pairs of parameters were investigated.
Results and Discussion
We focus the
discussion on findings related to water content, VBM and regions showing
highest degree of changes of quantitative parameters.
Fig. 1 shows water
content maps of a selected slice from the group-averaged volumes (left, T2DM;
right, controls) and the corresponding histograms. The diabetic brain displays
a shift in the water content distribution; its mean value over the whole brain is
2%.
The VBM analysis
revealed hypertrofic regions in diabetes to be: anterior
and posterior lobe of right cerebellum, anterior lobe of left cerebellum, right precentral gyrus and the superior
temporal gyrus/insula. Atrophy was found in the inferior,
medial, superior frontal gyri (bilateral), orbitofrontal cortex, right parahippocampal gyrus, anterior and middle
cingulum, bilateral fusiform gyri and lingual gyrus. Interestingly, changes in
the different quantitative parameters based on the 3D protocol did not reach
the significance level (p<0.05) in any of the regions highlighted by VBM,
but the trend showed a reduced increase in water content compared to the
noticed global increase.
Global white and grey matter, the thalamus and
temporal white matter showed significant changes, followed closely by changes
in corpus callosum (CC) and hypothalamus (HT) with 0.05<p<0.1.
Decreased
susceptibility values (more paramagnetic) were found in the basal ganglia
(pallidum, putamen, caudate), as usually associated with neurodegenerative
diseases.
We summarise our qMRI
findings in Fig. 2, where regions defined by Freesurfer are colour coded by the
number of parameters with significant changes (p<0.1)
Conclusions
We report here for the first time a generalized
increase in brain water content in type II diabetics compared to age- and
gender-matched controls. A substantial number of regions displaying changes in
several quantitative parameters are identified.
Acknowledgements
This
work is funded in part by the Helmholtz Alliance ICEMED - Imaging and Curing
Environmental Metabolic Diseases, through the Initiative and Network Fund of
the Helmholtz Association.
References
1.
L. Guariguata, D.R.
Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, J.E. Shaw, Global estimates
of diabetes prevalence for 2013 and projections for 2035, In Diabetes Research
and Clinical Practice, Volume 103, Issue 2, 2014, Pages 137-149, ISSN
0168-8227, https://doi.org/10.1016/j.diabres.2013.11.002.
2.
DeJong RN. CNS manifestations of diabetes
mellitus. Postgrad Med. 1977 Jan;61(1):101-7.
3.
Gispen WH, Biessels GJ.
Cognition and synaptic plasticity in diabetes mellitus. Trends
Neurosci. 2000;23:542–549.
4. Luchsinger JA, Tang MX, Stern Y, Shea S,
Mayeux R (2001) Diabetes
mellitus and risk of Alzheimer's disease and dementia with stroke in a
multiethnic cohort. Am J Epidemiol 154: 635-641.
5. Moran, C., Phan, T. G., Chen, J.,
Blizzard, L., Beare, R., Venn, A., … Srikanth, V. (2013). Brain atrophy in
type 2 diabetes: Regional distribution and influence on cognition. Diabetes
Care, 36(12), 4036–4042.
6.
Shukla, V., Shakya, A.
K., Perez-Pinzon, M. A., & Dave, K. R. (2017). Cerebral ischemic damage in
diabetes: an inflammatory perspective. Journal of Neuroinflammation, 14(1), 21.
7.
Caspers, S., Moebus, S., Lux, S., Pundt,
N., Schütz, H., Mühleisen, T. W., … Amunts, K. (2014). Studying variability in human
brain aging in a population-based German cohort-rationale and design of
1000BRAINS. Frontiers in Aging Neuroscience, 6(JUL), 1–14.
8.
Schall, M., Zimmermann, M., Iordanishvili, E., Gu, Y., Shah,
N.J., Oros-Peusquens, A.-M., Quantitative In Vivo Imaging Using a 3D Two-Point
Method, Magn Reson Mater Phy (2017), abstract ID 247
9.
Yarnykh, V., Actual flip-angle
imaging in the pulsed steady state: A method for rapid three-dimensional
mapping of the transmitted radiofrequency field, Magnetic Resonance in
Medicine, 2007, 57(1):192-200
10.
https://people.eecs.berkeley.edu/~chunlei.liu/software.html
11.
Neto Henriques et al,
MAGMA, 2015